CARA DAUFELDT: Open Payments
NPI 1073005351 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 81 payments from 20 companies in 2025. Trend: 2023 $555 · 2024 $981 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $373 |
| ABBVIE INC. | 27 | $252 |
| Tris Pharma Inc | 5 | $235 |
| AstraZeneca Pharmaceuticals LP | 5 | $144 |
| PFIZER INC. | 4 | $84 |
| Astellas Pharma US Inc | 3 | $74 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Corcept Therapeutics | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
Products named: Dyanavel XR, VRAYLAR, Ozempic, FARXIGA, Wegovy, Veozah, PREVNAR 20, Rybelsus.
Industry payments across OH — which companies pay providers there.
